El neuroblastoma en Costa Rica: experiencia con 76 casos tratados en el Hospital Nacional de Niños
Lobo Sanahuja, Francisco; Carranza, Alfonso; García Ivette; Barrantes, Max; Camacho Morales, Alvaro.
Bol. méd. Hosp. Infant. Méx
; 48(6): 426-33, jun. 1991. ilus, tab
Artículo en Español | LILACS | ID: lil-105126
Documentos relacionados
TNM classification of gynaecological malignant tumours, eighth edition: changes between the seventh and eighth editions.
Association of image-defined risk factors with clinical features, tumor biology, and outcomes in neuroblastoma: a single-center retrospective study.
Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting.
Biological features and clinical outcome in infant neuroblastoma: a multicenter experience in Beijing.
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Introducing the eighth edition of the tumor-node-metastasis classification as relevant to colorectal cancer, anal cancer and appendiceal cancer: a comparison study with the seventh edition of the tumor-node-metastasis and the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma.
Prognosis of Concurrent Versus Sequential Chemo-Radiotherapy Induction Followed by Surgical Resection in Patients with Advanced Thymic Epithelial Tumors: A Retrospective Study.
Prognostic impact of the subclassification of Müllerian cancer stage IV in the FIGO 2014 staging system with a focus of extra-abdominal lymph node metastases.